API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Carrageenan and its applications in drug delivery

Carrageenan, derived from seaweed, is used as an extrusion aid and stabilizer in drug delivery systems, enhancing pellet properties and emulsion stability.

Feb 5,2024  API

Dilauroyl Peroxide: A Versatile Compound in Polymerization with Significant Safety Considerations

Dilauroyl peroxide is a useful compound in polymerization, synthesized from lauroyl chloride and hydrogen peroxide, but requires careful handling due to its explosive nature.

Feb 5,2024  API

Ethyl propiolate: A Versatile Compound with Applications in Pyrazole Synthesis and Gasoline Additives

Ethyl propiolate's synthesis involves esterification or transesterification reactions. It is utilized in pyrazole synthesis and as a gasoline additive for improved combustion performance.

Feb 5,2024  API

Nobiletin: A Promising Citrus-Derived Compound with Anti-Cancer and Anti-Immune-Modulating Properties

Nobiletin, from citrus fruits, exhibits anti-cancer, anti-inflammatory, and antioxidant properties, making it a promising candidate for combination cancer therapy.

Feb 5,2024  API

Sodium Pyrithione: Versatile Fungicide with Diverse Applications and Safety Considerations

Sodium Pyrithione, a versatile fungicide, is used widely in diverse industries, but caution is necessary to minimize potential risks.

Feb 5,2024  API

Sodium allylsulfonate: Versatile Properties, Industrial Applications, and Hazards

Sodium allylsulfonate is a reactive polymer surfactant used in textiles and nickel plating, but requires caution due to toxicity risks.

Feb 5,2024  API

trans-Cinnamaldehyde: A Natural Compound with Potentiating Effects in Bacteria and Fungi

trans-Cinnamaldehyde, derived from cinnamon bark, shows potential in combating antibiotic-resistant bacteria and enhancing antifungal treatments.

Feb 5,2024  API

Afoxolaner: An Effective Insecticide and Acaricide for Flea and Tick Infestations in Dogs

Afoxolaner is an isoxazoline insecticide used for treating flea and tick infestations in dogs. It inhibits chloride ion channels, providing efficient killing upon contact or ingestion.

Feb 5,2024  API

How to synthesize Trastuzumab Deruxtecan?

Preparation of the final drug product, trastuzumab deruxtecan, necessitated conjugation of deruxtecan to the anti-HER2 monoclonal antibody trastuzumab, generating the ADC with a loading of approximat

Feb 4,2024  API

The introduction of Trastuzumab Deruxtecan

Trastuzumab deruxtecan, a HER2-directed antibody and DNA topoisomerase I inhibitor conjugate, is being developed for the treatment of HER2-expressing solid tumors.

Feb 4,2024  API
Prev12345678910...Next>  Go to Page